The Treatment of Hyponatremia

Seminars in Nephrology

Volumn 29, Issue 3, 2009, Pages 282-299

  Sterns, Richard H ^a   Nigwekar, Sagar U ^a   Hix, John Kevin ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

cerebral edema; hypertonic saline; Hyponatremia; myelinolysis; osmotic demyelination syndrome

Indexed keywords

CONIVAPTAN; DESMOPRESSIN ACETATE; GLUCOSE; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; POTASSIUM CHLORIDE; SATAVAPTAN; SODIUM; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; TOLVAPTAN; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN V2 RECEPTOR ANTAGONIST;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; ACUTE TOXICITY; ADRENAL INSUFFICIENCY; ANOXIA; ARTICLE; BOLUS INJECTION; BRAIN DAMAGE; BRAIN EDEMA; CHRONIC DISEASE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DEMYELINATING NEUROPATHY; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; DIURESIS; DRUG EFFICACY; DRUG MECHANISM; ELECTROLYTE DISTURBANCE; HUMAN; HYPOKALEMIA; HYPONATREMIA; IATROGENIC DISEASE; INAPPROPRIATE VASOPRESSIN SECRETION; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SYMPTOM; THERAPEUTIC ERROR; THERAPY DELAY; URINE VOLUME; WATER INTOXICATION;

BRAIN; HUMANS; HYPONATREMIA; RISK FACTORS; SALINE SOLUTION, HYPERTONIC;

EID: 66449097744     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.03.002     Document Type: Article

References (133)

1. Norenberg M.D., Leslie K.O., and Robertson A.S. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol 11 (1982) 128-135
2. Kleinschmidt-DeMasters B.K., and Norenberg M.D. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science 211 (1981) 1068-1070
3. Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol 13 (1983) 232-242
4. Laureno R. Rapid correction of hyponatremia: cause of pontine myelinolysis?. Am J Med 71 (1981) 846-847
5. Laureno R. Experimental pontine and extrapontine myelinolysis. Trans Am Neurol Assoc 105 (1980) 354-358
6. Ashraf N., Locksley R., and Arieff A.I. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70 (1981) 1163-1168
7. Ayus J.C., Olivero J.J., and Frommer J.P. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution. Am J Med 72 (1982) 43-48
8. Sterns R.H. The management of symptomatic hyponatremia. Semin Nephrol 10 (1990) 503-514
9. Berl T. Treating hyponatremia: damned if we do and damned if we don't. Kidney Int 37 (1990) 1006-1018
10. Hew-Butler T., Ayus J.C., Kipps C., Maughan R.J., Mettler S., Meeuwisse W.H., et al. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med 18 (2008) 111-121
11. Decaux G., and Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci 326 (2003) 25-30
12. Adrogue H.J., and Madias N.E. Hyponatremia. N Engl J Med 342 (2000) 1581-1589
13. Verbalis J.G., Goldsmith S.R., Greenberg A., Schrier R.W., and Sterns R.H. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 120 Suppl 1 (2007) S1-S21
14. Achinger S.G., Moritz M.L., and Ayus J.C. Dysnatremias: why are patients still dying?. South Med J 99 (2006) 353-364
15. Halperin M.L., and Kamel K.S. A new look at an old problem: therapy of chronic hyponatremia. Nat Clin Pract Nephrol 3 (2007) 2-3
16. Ellison D.H., and Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356 (2007) 2064-2072
17. Lien Y.H., and Shapiro J.I. Hyponatremia: clinical diagnosis and management. Am J Med 120 (2007) 653-658
18. Rowntree L.G. Effects on mammals of the administration of excessive quantities of water. J Pharmacol Exp Ther 29 (1926) 135-159
19. Helwig F.C., Schutz C.B., and Curry D.E. Water intoxication. Report of a fatal case, with clinical, pathologic and experimental studies. JAMA 104 (1935) 1539-1575
20. Helwig F.C., Schutz C.B., and Kuhn H.P. Water intoxication. Moribund patient cured by administration of hypertonic salt solution. JAMA 110 (1938) 644-645
21. Yannet H. Changes in the brain resulting from depletion of extracellular electrolytes. Am J Physiol 128 (1940) 683-689
22. Arieff A.I., Llach F., and Massry S.G. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 55 (1976) 121-129
23. Arieff A.I. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 314 (1986) 1529-1535
24. Ayus J.C., Wheeler J.M., and Arieff A.I. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 117 (1992) 891-897
25. Arieff A.I., Ayus J.C., and Fraser C.L. Hyponatraemia and death or permanent brain damage in healthy children. BMJ 304 (1992) 1218-1222
26. Ayus J.C., and Arieff A.I. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA 281 (1999) 2299-2304
27. Arieff A.I. Postoperative hyponatraemic encephalopathy following elective surgery in children. Paediatr Anaesth 8 (1998) 1-4
28. Ayus J.C., and Arieff A.I. Pulmonary complications of hyponatremic encephalopathy. noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest 107 (1995) 517-521
29. Raskind M. Psychosis, polydipsia, and water intoxication. Report of a fatal case. Arch Gen Psychiatry 30 (1974) 112-114
30. O'Brien K.K., Montain S.J., Corr W.P., Sawka M.N., Knapik J.J., and Craig S.C. Hyponatremia associated with overhydration in U.S. Army trainees. Mil Med 166 (2001) 405-410
31. Gardner J.W., and Gutmann F.D. Fatal water intoxication of an Army trainee during urine drug testing. Mil Med 167 (2002) 435-437
32. Chen X., and Huang G. Autopsy case report of a rare acute iatrogenic water intoxication with a review of the literature. Forensic Sci Int 76 (1995) 27-34
33. Tomlinson B.E., Pierides A.M., and Bradley W.G. Central pontine myelinolysis. Two cases with associated electrolyte disturbance. QJM 45 (1976) 373-386
34. Adams R.D., Victor M., and Mancall E.L. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 81 (1959) 154-172
35. Wright D.G., Laureno R., and Victor M. Pontine and extrapontine myelinolysis. Brain 102 (1979) 361-385
36. Norenberg M.D., and Papendick R.E. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann Neurol 15 (1984) 544-547
37. Sugimura Y., Murase T., Takefuji S., Hayasaka S., Takagishi Y., Oiso Y., et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 192 (2005) 178-183
38. Brown W.D. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol 13 (2000) 691-697
39. Karp B.I., and Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore) 72 (1993) 359-373
40. Brunner J.E., Redmond J.M., Haggar A.M., Kruger D.F., and Elias S.B. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 27 (1990) 61-66
41. Sterns R.H., Riggs J.E., and Schochet Jr. S.S. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314 (1986) 1535-1542
42. Verbalis J.G., and Martinez A.J. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int 39 (1991) 1274-1282
43. Rojiani A.M., Cho E.S., Sharer L., and Prineas J.W. Electrolyte-induced demyelination in rats. 2. Ultrastructural evolution. Acta Neuropathol (Berl) 88 (1994) 293-299
44. Rojiani A.M., Prineas J.W., and Cho E.S. Electrolyte-induced demyelination in rats. 1. Role of the blood-brain barrier and edema. Acta Neuropathol (Berl) 88 (1994) 287-292
45. Sterns R.H., Cappuccio J.D., Silver S.M., and Cohen E.P. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 4 (1994) 1522-1530
46. Tanneau R.S., Henry A., Rouhart F., Bourbigot B., Garo B., Mocquard Y., et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J Clin Psychiatry 55 (1994) 349-354
47. Ellis S.J. Severe hyponatraemia: complications and treatment. QJM 88 (1995) 905-909
48. Newell K.L., and Kleinschmidt-DeMasters B.K. Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci 142 (1996) 134-139
49. Abbasoglu O., Goldstein R.M., Vodapally M.S., Jennings L.W., Levy M.F., Husberg B.S., et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 12 (1998) 263-269
50. Martin R.J. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 75 Suppl 3 (2004) iii22-iii28
51. Abbott R., Silber E., Felber J., and Ekpo E. Osmotic demyelination syndrome. BMJ 331 (2005) 829-830
52. Kleinschmidt-Demasters B.K., Rojiani A.M., and Filley C.M. Central and extrapontine myelinolysis: then ... and now. J Neuropathol Exp Neurol 65 (2006) 1-11
53. Sterns R.H., and Silver S.M. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med 119 Suppl 1 (2006) S12-S16
54. Thurston J.H., and Hauhart R.E. Brain amino acids decrease in chronic hyponatremia and rapid correction causes brain dehydration: possible clinical significance. Life Sci 40 (1987) 2539-2542
55. Thurston J.H., Hauhart R.E., and Nelson J.S. Adaptive decreases in amino acids (taurine in particular), creatine, and electrolytes prevent cerebral edema in chronically hyponatremic mice: rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain. Metab Brain Dis 2 (1987) 223-241
56. Lien Y.H., Shapiro J.I., and Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 88 (1991) 303-309
57. Sterns R.H., Baer J., Ebersol S., Thomas D., Lohr J.W., and Kamm D.E. Organic osmolytes in acute hyponatremia. Am J Physiol 264 (1993) F833-F836
58. Sterns R.H., Thomas D.J., and Herndon R.M. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int 35 (1989) 69-75
59. Verbalis J.G., and Gullans S.R. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res 567 (1991) 274-282
60. Verbalis J.G., and Gullans S.R. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res 606 (1993) 19-27
61. Lien Y.H. Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia. J Clin Invest 95 (1995) 1579-1586
62. Soupart A., Silver S., Schrooeder B., Sterns R., and Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol 13 (2002) 1433-1441
63. Silver S.M., Schroeder B.M., Sterns R.H., and Rojiani A.M. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol 65 (2006) 37-44
64. Silver S.M., Schroeder B.M., and Sterns R.H. Brain uptake of myoinositol after exogenous administration. J Am Soc Nephrol 13 (2002) 1255-1260
65. Baker E.A., Tian Y., Adler S., and Verbalis J.G. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia. Exp Neurol 165 (2000) 221-230
66. Norenberg M.D. A hypothesis of osmotic endothelial injury. A pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 40 (1983) 66-69
67. DeLuca G.C., Nagy Z., Esiri M.M., and Davey P. Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol (Berl) 103 (2002) 590-598
68. Ashrafian H., and Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness?. Eur J Neurol 8 (2001) 103-109
69. Maallem S., Mutin M., Gonzalez-Gonzalez I.M., Zafra F., and Tappaz M.L. Selective tonicity-induced expression of the neutral amino-acid transporter SNAT2 in oligodendrocytes in rat brain following systemic hypertonicity. Neuroscience 153 (2008) 95-107
70. Maallem S., Mutin M., Kwon H.M., and Tappaz M.L. Differential cellular distribution of tonicity-induced expression of transcription factor TonEBP in the rat brain following prolonged systemic hypertonicity. Neuroscience 137 (2006) 51-71
71. Clifford D.B., Gado M.H., and Levy B.K. Osmotic demyelination syndrome. Lack of pathologic and radiologic imaging correlation. Arch Neurol 46 (1989) 343-347
72. Sterns R.H. Neurological deterioration following treatment for hyponatremia. Am J Kidney Dis 13 (1989) 434-437
73. Plum F., Posner J.B., and Hain R.F. Delayed neurological deterioration after anoxia. Arch Intern Med 110 (1962) 18-25
74. Thacker A.K., Asthana A.B., and Sarkari N.B. Delayed post-anoxic encephalopathy. Postgrad Med J 71 (1995) 373-374
75. Chow K.M., Kwan B.C., and Szeto C.C. Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc 96 (2004) 1305-1308
76. Ayus J.C., Achinger S.G., and Arieff A. Brain cell volume regulation in hyponatremia: role of gender, age, vasopressin and hypoxia. Am J Physiol Renal Physiol 268 (2008) R1143-R1152
77. Ayus J.C., Armstrong D., and Arieff A.I. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int 69 (2006) 1319-1325
78. Vexler Z.S., Ayus J.C., Roberts T.P., Fraser C.L., Kucharczyk J., and Arieff A.I. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. J Clin Invest 93 (1994) 256-264
79. Soupart A., Penninckx R., Stenuit A., and Decaux G. Lack of major hypoxia and significant brain damage in rats despite dramatic hyponatremic encephalopathy. J Lab Clin Med 130 (1997) 226-231
80. Dubois G.D., and Arieff A.I. Treatment of hyponatremia: the case for rapid correction. In: Narins R.G. (Ed). Controversies in nephrology and hypertension (1984), Churchill Livingstone, Philadelphia 393-407
81. Norenberg M. Treatment of hyponatremia: the case for more conservative management. In: Narins R.G. (Ed). Controversies in nephrology and hypertension (1984), Churchill Livingstone, New York 379-391
82. Ayus J.C., Krothapalli R.K., and Arieff A.I. Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. Am J Med 78 (1985) 897-902
83. Sterns R.H. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann Intern Med 107 (1987) 656-664
84. Ayus J.C., Krothapalli R.K., and Arieff A.I. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med 317 (1987) 1190-1195
85. Silver S.M., Kozlowski S.A., Baer J.E., Rogers S.J., and Sterns R.H. Glycine-induced hyponatremia in the rat: a model of post-prostatectomy syndrome. Kidney Int 47 (1995) 262-268
86. Cluitmans F.H., and Meinders A.E. Management of severe hyponatremia: rapid or slow correction?. Am J Med 88 (1990) 161-166
87. Hantman D., Rossier B., Zohlman R., and Schrier R. Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline. Ann Intern Med 78 (1973) 870-875
88. Cherney D.Z., Davids M.R., and Halperin M.L. Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis. QJM 95 (2002) 475-483
89. Steele A., Gowrishankar M., Abrahamson S., Mazer C.D., Feldman R.D., and Halperin M.L. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann Intern Med 126 (1997) 20-25
90. Rae J. Self-induced water intoxication in a schizophrenic patient. Can Med Assoc J 114 (1976) 438-439
91. Snell D.M., and Bartley C. Osmotic demyelination syndrome following rapid correction of hyponatraemia. Anaesthesia 63 (2008) 92-95
92. Schreiber A., Kubitza S., and Luft F.C. A woman with postoperative hyponatremia related to desmopressin acetate. Am J Kidney Dis 44 (2004) e3-e6
93. Goudie A.M., Tunstall-Pedoe D.S., and Kerins M. Altered mental status after a marathon. N Engl J Med 352 (2005) 1613-1614
94. Worthley L.I., and Thomas P.D. Treatment of hyponatraemic seizures with intravenous 29.2% saline. Br Med J (Clin Res Ed) 292 (1986) 168-170
95. Drescher T., Klima T., and Schifferli J. Seizures, hyponatraemia, and "poison". Lancet 371 (2008) 2144
96. Speedy D.B., Rogers I., Safih S., and Foley B. Hyponatremia and seizures in an ultradistance triathlete. J Emerg Med 18 (2000) 41-44
97. Hew-Butler T., Noakes T.D., and Siegel A.J. Practical management of exercise-associated hyponatremic encephalopathy: the sodium paradox of non-osmotic vasopressin secretion. Clin J Sport Med 18 (2008) 350-354
98. Goudie A.M., Tunstall-Pedoe D.S., Kerins M., and Terris J. Exercise-associated hyponatraemia after a marathon: case series. J R Soc Med 99 (2006) 363-367
99. Hew-Butler T., Anley C., Schwartz P., and Noakes T. The treatment of symptomatic hyponatremia with hypertonic saline in an Ironman triathlete. Clin J Sport Med 17 (2007) 68-69
100. Fisher A., Davis M., Croft-Baker J., Purcell P., and McLean A. Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug React Toxicol Rev 21 (2002) 179-187
101. Koenig M.A., Bryan M., Lewin III J.L., Mirski M.A., Geocadin R.G., and Stevens R.D. Reversal of transtentorial herniation with hypertonic saline. Neurology 70 (2008) 1023-1029
102. Bentsen G., Breivik H., Lundar T., and Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med 34 (2006) 2912-2917
103. Tseng M.Y., Al-Rawi P.G., Czosnyka M., Hutchinson P.J., Richards H., Pickard J.D., et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg 107 (2007) 274-282
104. Chuang Y.C., Chang C.S., Hsu S.P., Lin T.K., and Lui C.C. Osmotic demyelination syndrome with two-phase movement disorders: case report. Changgeng Yi Xue Za Zhi 21 (1998) 526-530
105. Dellabarca C., Servilla K.S., Hart B., Murata G.H., and Tzamaloukas A.H. Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations. Int Urol Nephrol 37 (2005) 171-173
106. Leens C., Mukendi R., Foret F., Hacourt A., Devuyst O., and Colin I.M. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol 55 (2001) 248-253
107. Yu J., Zheng S.S., Liang T.B., Shen Y., Wang W.L., and Ke Q.H. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol 10 (2004) 2540-2543
108. Pradhan S., Jha R., Singh M.N., Gupta S., Phadke R.V., and Kher V. Central pontine myelinolysis following 'slow' correction of hyponatremia. Clin Neurol Neurosurg 97 (1995) 340-343
109. Renneboog B., Musch W., Vandemergel X., Manto M.U., and Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119 (2006) 71e1-8
110. Gankam Kengne F., Andres C., Sattar L., Melot C., and Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101 (2008) 583-588
111. Furst H., Hallows K.R., Post J., Chen S., Kotzker W., Goldfarb S., et al. The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci 319 (2000) 240-244
112. Edelman I.S., Leibman J., O'Meara M.W., and Birkenfeld L.W. Interrelations between serum sodium concentrations, serum osmolality and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 37 (1958) 1236-1256
113. Nguyen M.K., and Kurtz I. Role of potassium in hypokalemia-induced hyponatremia: lessons learned from the Edelman equation. Clin Exp Nephrol 8 (2004) 98-102
114. Fichman M.P., Vorherr H., Kleeman C.R., and Telfer N. Diuretic-induced hyponatremia. Ann Intern Med 75 (1971) 853-863
115. Perianayagam A., Sterns R.H., Silver S.M., Grieff M., Mayo R., Hix J., et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 3 (2008) 331-336
116. Mohmand H.K., Issa D., Ahmad Z., Cappuccio J.D., Kouides R.W., and Sterns R.H. Hypertonic saline for hyponatremia: the risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2 (2007) 1110-1117
117. Liamis G., Kalogirou M., Saugos V., and Elisaf M. Therapeutic approach in patients with dysnatraemias. Am J Kidney Dis 52 (2008) 144-153
118. Pham P.C., Chen P.V., and Pham P.T. Overcorrection of hyponatremia: where do we go wrong?. Am J Kidney Dis 36 (2000) E12
119. Oh M.S., Uribarri J., Barrido D., Landman E., Choi K.C., and Carroll H.J. Danger of central pontine myelinolysis in hypotonic dehydration and recommendation for treatment. Am J Med Sci 298 (1989) 41-43
120. Mohmand H.K., Issa D., Ahmad Z., Cappuccio J.D., Kouides R.W., and Sterns R.H. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol 2 (2007) 1110-1117
121. Adrogue H.J., and Madias N.E. Aiding fluid prescription for the dysnatremias. Intensive Care Med 23 (1997) 309-316
122. Soupart A., Penninckx R., Stenuit A., Perier O., and Decaux G. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms. J Neuropathol Exp Neurol 55 (1996) 594-601
123. Soupart A., Ngassa M., and Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol 51 (1999) 383-386
124. Oya S., Tsutsumi K., Ueki K., and Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology 57 (2001) 1931-1932
125. Croxson M., Lucas J., and Bagg W. Diluting delirium. N Z Med J 118 (2005) U1661
126. Greenberg A., and Verbalis J.G. Vasopressin receptor antagonists. Kidney Int 69 (2006) 2124-2130
127. Verbalis J.G., Zeltser D., Smith N., Barve A., and Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolemic hyponatremia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf) 69 (2008) 159-168
128. Schrier R., Gross P., Gheorghiade M., Berl T., Verbalis J.G., Czerwiec F.S., et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355 (2006) 2099-2112
129. Udelson J.E., Smith W.B., Hendrix G.H., Painchaud C.A., Ghazzi M., Thomas I., et al. Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation 104 (2001) 2417-2423
130. 2receptor antagonist. Clin J Am Soc Nephrol 1 (2006) 1154-1160
131. Zeltser D., Rosansky S., van Rensburg H., Verbalis J.G., and Smith N. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 27 (2007) 447-457
132. Schrier R.W., Gross P., Gheorghiade M., Berl T., Verbalis J.G., Czerwiec F.S., et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355 (2006) 2099-2112
133. Verbalis J., and Martinez A. Determinants of brain myelinolysis following correction of chronic hyponatremia in rats. In: Jard S., and Jameson R.L. (Eds). Vasopressin (1991), John Libby, Paris 539-547